vs
Finwise Bancorp（FINW）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是Finwise Bancorp的1.8倍（$75.5M vs $42.7M），过去两年Finwise Bancorp的营收复合增速更高（47.0% vs 31.3%）
Finwise Bancorp是一家总部位于美国的金融控股公司，主要通过旗下社区银行子公司开展业务，提供存款账户、个人贷款、抵押贷款、小微企业融资、财富管理等多元化金融服务，服务覆盖区域内的零售消费者和中小微企业客户。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
FINW vs PBYI — 直观对比
营收规模更大
PBYI
是对方的1.8倍
$42.7M
两年增速更快
FINW
近两年复合增速
31.3%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $42.7M | $75.5M |
| 净利润 | $2.7M | — |
| 毛利率 | — | 69.3% |
| 营业利润率 | — | 22.7% |
| 净利率 | 6.4% | — |
| 营收同比 | — | 27.7% |
| 净利润同比 | — | — |
| 每股收益（稀释后） | $0.20 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FINWPBYI
| Q1 26 | $42.7M | — | ||
| Q4 25 | $46.9M | $75.5M | ||
| Q3 25 | $36.7M | $54.5M | ||
| Q2 25 | $25.1M | $52.4M | ||
| Q1 25 | $22.1M | $46.0M | ||
| Q4 24 | $21.1M | $59.1M | ||
| Q3 24 | $20.8M | $80.5M | ||
| Q2 24 | $19.8M | $47.1M |
净利润FINWPBYI
| Q1 26 | $2.7M | — | ||
| Q4 25 | $3.9M | — | ||
| Q3 25 | $4.9M | $8.8M | ||
| Q2 25 | $4.1M | $5.9M | ||
| Q1 25 | $3.2M | $3.0M | ||
| Q4 24 | $2.8M | — | ||
| Q3 24 | $3.5M | $20.3M | ||
| Q2 24 | $3.2M | $-4.5M |
毛利率FINWPBYI
| Q1 26 | — | — | ||
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% |
营业利润率FINWPBYI
| Q1 26 | — | — | ||
| Q4 25 | 11.7% | 22.7% | ||
| Q3 25 | 17.5% | 17.6% | ||
| Q2 25 | 21.7% | 12.7% | ||
| Q1 25 | 20.1% | 8.7% | ||
| Q4 24 | 17.5% | 22.6% | ||
| Q3 24 | 22.2% | 27.4% | ||
| Q2 24 | 21.1% | -4.6% |
净利率FINWPBYI
| Q1 26 | 6.4% | — | ||
| Q4 25 | 8.4% | — | ||
| Q3 25 | 13.3% | 16.2% | ||
| Q2 25 | 16.3% | 11.2% | ||
| Q1 25 | 14.4% | 6.5% | ||
| Q4 24 | 13.2% | — | ||
| Q3 24 | 16.6% | 25.2% | ||
| Q2 24 | 16.1% | -9.6% |
每股收益（稀释后）FINWPBYI
| Q1 26 | $0.20 | — | ||
| Q4 25 | $0.27 | $0.26 | ||
| Q3 25 | $0.34 | $0.17 | ||
| Q2 25 | $0.29 | $0.12 | ||
| Q1 25 | $0.23 | $0.06 | ||
| Q4 24 | $0.19 | $0.40 | ||
| Q3 24 | $0.25 | $0.41 | ||
| Q2 24 | $0.24 | $-0.09 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $97.5M |
| 总债务越低越好 | — | $22.7M |
| 股东权益账面价值 | $196.6M | $130.3M |
| 总资产 | $899.4M | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资FINWPBYI
| Q1 26 | — | — | ||
| Q4 25 | $163.4M | $97.5M | ||
| Q3 25 | $105.6M | $94.4M | ||
| Q2 25 | $90.1M | $96.0M | ||
| Q1 25 | $120.3M | $93.2M | ||
| Q4 24 | $109.2M | $101.0M | ||
| Q3 24 | $85.8M | $96.7M | ||
| Q2 24 | $89.0M | $96.8M |
总债务FINWPBYI
| Q1 26 | — | — | ||
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M |
股东权益FINWPBYI
| Q1 26 | $196.6M | — | ||
| Q4 25 | $193.2M | $130.3M | ||
| Q3 25 | $187.8M | $115.3M | ||
| Q2 25 | $182.0M | $104.7M | ||
| Q1 25 | $177.4M | $97.1M | ||
| Q4 24 | $173.7M | $92.1M | ||
| Q3 24 | $170.4M | $71.1M | ||
| Q2 24 | $165.8M | $48.5M |
总资产FINWPBYI
| Q1 26 | $899.4M | — | ||
| Q4 25 | $977.1M | $216.3M | ||
| Q3 25 | $899.9M | $202.9M | ||
| Q2 25 | $842.5M | $194.9M | ||
| Q1 25 | $804.1M | $196.2M | ||
| Q4 24 | $746.0M | $213.3M | ||
| Q3 24 | $683.0M | $220.7M | ||
| Q2 24 | $617.8M | $205.0M |
负债/权益比FINWPBYI
| Q1 26 | — | — | ||
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $14.4M |
| 自由现金流经营现金流 - 资本支出 | — | $14.4M |
| 自由现金流率自由现金流/营收 | — | 19.1% |
| 资本支出强度资本支出/营收 | — | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $41.7M |
8季度趋势，按日历期对齐
经营现金流FINWPBYI
| Q1 26 | — | — | ||
| Q4 25 | $-28.4M | $14.4M | ||
| Q3 25 | $3.5M | $9.7M | ||
| Q2 25 | $-18.3M | $14.1M | ||
| Q1 25 | $-21.6M | $3.6M | ||
| Q4 24 | $-15.0M | $15.6M | ||
| Q3 24 | $-9.8M | $11.0M | ||
| Q2 24 | $-7.6M | $1.0M |
自由现金流FINWPBYI
| Q1 26 | — | — | ||
| Q4 25 | $-28.6M | $14.4M | ||
| Q3 25 | $3.4M | $9.7M | ||
| Q2 25 | $-19.8M | $14.1M | ||
| Q1 25 | $-23.3M | $3.6M | ||
| Q4 24 | $-16.1M | $15.6M | ||
| Q3 24 | $-13.4M | $11.0M | ||
| Q2 24 | $-7.7M | $1.0M |
自由现金流率FINWPBYI
| Q1 26 | — | — | ||
| Q4 25 | -61.1% | 19.1% | ||
| Q3 25 | 9.4% | 17.7% | ||
| Q2 25 | -79.0% | 26.8% | ||
| Q1 25 | -105.3% | 7.7% | ||
| Q4 24 | -76.0% | 26.4% | ||
| Q3 24 | -64.3% | 13.7% | ||
| Q2 24 | -38.7% | 2.1% |
资本支出强度FINWPBYI
| Q1 26 | — | — | ||
| Q4 25 | 0.5% | 0.0% | ||
| Q3 25 | 0.1% | 0.0% | ||
| Q2 25 | 5.8% | 0.0% | ||
| Q1 25 | 7.4% | 0.1% | ||
| Q4 24 | 5.1% | 0.0% | ||
| Q3 24 | 17.2% | 0.0% | ||
| Q2 24 | 0.3% | 0.0% |
现金转化率FINWPBYI
| Q1 26 | — | — | ||
| Q4 25 | -7.26× | — | ||
| Q3 25 | 0.71× | 1.10× | ||
| Q2 25 | -4.48× | 2.41× | ||
| Q1 25 | -6.78× | 1.21× | ||
| Q4 24 | -5.37× | — | ||
| Q3 24 | -2.84× | 0.54× | ||
| Q2 24 | -2.39× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FINW
| Net Interest Income | $28.1M | 66% |
| Noninterest Income | $14.6M | 34% |
PBYI
暂无分部数据
